254
Views
16
CrossRef citations to date
0
Altmetric
In Vitro and Animal Studies

Hydrolysed fumonisin B1 and N-(deoxy-D-fructos-1-yl)-fumonisin B1: stability and catabolic fate under simulated human gastrointestinal conditions

, , , , , , , & show all
Pages 98-103 | Received 27 Jun 2014, Accepted 07 Oct 2014, Published online: 04 Dec 2014
 

Abstract

Food processing may induce thermal degradation of fumonisins in corn via Maillard-type reactions, or alkaline hydrolysis via loss of the two tricarballylic acid moieties. In the former case, N-(1-deoxy-D-fructos-1-yl)-fumonisin B1 (NDF) can be formed, while the latter derivative is called hydrolysed fumonisin B1 (HFB1). The aim of this study was to deepen the knowledge about the gastrointestinal stability of HFB1 and NDF in humans. Due to the lack of standard, NDF was chemically synthesised and cleaned up in high purity to be used for further experiments. While NDF is already partially cleaved (about 41%) during simulated digestion, it remained rather stable towards human colon microflora. In contrast to this, HFB1 is partially metabolised by the colon microflora to unknown compounds after 24 h of fermentation, as seen by a loss of about 22%. Concluding, the cleavage of NDF during digestion as well as the likely metabolisation of HFB1 emphasise the need for animal trials to ascertain their toxicity in vivo.

Declaration of interest

The authors want to acknowledge the FIRB-Futuro in Ricerca program, Italian Ministry of University and Research for granting this research activity. Furthermore, we want to acknowledge the Austrian Federal Ministry of Science, Research and Economy, the National Foundation for Research, Technology and Development, BIOMIN Holding GmbH and Nestec Ltd. for funding the Christian Doppler Laboratory for Mycotoxin Metabolism.

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article. This article does not contain any studies with human or animal subjects.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.